Find out everything you need to know about the latest COVID-19 booster shot here >

David W. Victor, III VIEW CLINICAL PROFILE

David W. Victor, III, MD

Associate Professor of Clinical Medicine, Academic Institute
Associate Clinical Member, Research Institute
Houston Methodist
Weill Cornell Medical College


VIEW CLINICAL PROFILE
Education & Training

MD, University of Kentucky College of Medicine
BA, Vanderbilt University
Clinical Fellowship, Johns Hopkins School of Medicine
Clinical Fellowship, Tulane University
Residency, Tulane University
Internship, Tulane University
Active Clinical Trials

A Study to Test Safety and Efficacy of BI456906 in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)

NCT00000000


A Phase 2a, Double-Blind, Randomized, Active Controlled, Parallel Group Study Evaluating the Efficacy, Safety, and Tolerability of Bezafibrate Administered in Combination with Obeticholic Acid in Subjects with Primary Biliary Cholangitis

NCT05239468


A randomized, double-blind, placebo-controlled, multicenter, Phase 3 study evaluating long-term efficacy and safety of lanifibranor in adult patients with non-cirrhotic non-alcoholic steatohepatitis (NASH) and fibrosis 2/fibrosis 3 stage of liver fibrosis

NCT04849728


A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multiple-dose Phase 2 Study to Evaluate the Efficacy and Safety of BMS-986263 in Adults with Compensated Cirrhosis from Nonalcoholic Steatohepatitis (NASH)

NCT04267393


The Effect of Semaglutide in Subjects with Non-cirrhotic Non-alcoholic Steatohepatitis (NASH)

NCT00000000


View All
Publications

Proceedings of the 26th Annual Virtual Congress of the International Liver Transplantation Society
Kalisvaart, M, Chadha, R, De Martin, E, Alconchel, F, Goldaracena, N, Keskin, O, Liu, J, Nasralla, D, Mazzola, A, Rammohan, A, Spiro, M, Tanaka, T, Campos-Varela, I, Victor, D, Vinaixa, C, Yoon, U, Yoon, YI, Hessheimer, A, Kabacam, G, Sapisochin, G, Shaker, T, Bhangui, P, Chan, A & Kirchner, V 2022, , Transplantation, vol. 106, no. 9, pp. 1738-1744. https://doi.org/10.1097/TP.0000000000004183

Gemcitabine Plus Cisplatin Versus Non-Gemcitabine and Cisplatin Regimens as Neoadjuvant Treatment for Cholangiocarcinoma Patients Prior to Liver Transplantation: An Institution Experience
Abdelrahim, M, Esmail, A, Xu, J, Umoru, G, Al-Rawi, H, Saharia, A, Abudayyeh, A, Victor, D, McMillan, R, Kodali, S & Ghobrial, RM 2022, , Frontiers in Oncology, vol. 12, 908687. https://doi.org/10.3389/fonc.2022.908687

Gemcitabine and Cisplatin as Neo-Adjuvant for Cholangiocarcinoma Patients Prior to Liver Transplantation: Case-Series
Abdelrahim, M, Al-Rawi, H, Esmail, A, Xu, J, Umoru, G, Ibnshamsah, F, Abudayyeh, A, Victor, D, Saharia, A, McMillan, R, Al Najjar, E, Bugazia, D, Al-Rawi, M & Ghobrial, RM 2022, , Current Oncology, vol. 29, no. 5, pp. 3585-3594. https://doi.org/10.3390/curroncol29050290

Perioperative cangrelor in patients with recent percutaneous coronary intervention undergoing liver transplantation: A case series
Succar, L, Lopez, CN, Victor, DW, Lindberg, SA, Saharia, A, Sheth, S & Mobley, CM 2022, , Pharmacotherapy, vol. 42, no. 3, pp. 263-267. https://doi.org/10.1002/phar.2661

Transarterial Chemoembolization (TACE) Plus Sorafenib Compared to TACE Alone in Transplant Recipients with Hepatocellular Carcinoma: An Institution Experience
Abdelrahim, M, Victor, D, Esmail, A, Kodali, S, Graviss, EA, Nguyen, DT, Moore, LW, Saharia, A, McMillan, R, Fong, JN, Uosef, A, Elshawwaf, M, Heyne, K & Ghobrial, RM 2022, , Cancers, vol. 14, no. 3, 650. https://doi.org/10.3390/cancers14030650

Perioperative cangrelor in patients with recent percutaneous coronary intervention undergoing liver transplantation: A case series
Succar, L, Lopez, CN, Victor, DW, Lindberg, SA, Saharia, A, Sheth, S & Mobley, CM 2022, , Pharmacotherapy, vol. 42, no. 3, pp. 263-267. https://doi.org/10.1002/phar.2661

Transplant oncology: An evolving field in cancer care
Abdelrahim, M, Esmail, A, Abudayyeh, A, Murakami, N, Saharia, A, McMillan, R, Victor, D, Kodali, S, Shetty, A, Fong, JVN, Moore, LW, Heyne, K, Gaber, AO & Ghobrial, RM 2021, , Cancers, vol. 13, no. 19, 4911. https://doi.org/10.3390/cancers13194911

Pre-transplant T-cell Clonality: An Observational Study of a Biomarker for Prediction of Sepsis in Liver Transplant Recipients
Jones, SL, Moore, LW, Li, XC, Mobley, CM, Fields, PA, Graviss, EA, Nguyen, DT, Nolte Fong, J, Saharia, A, Hobeika, MJ, McMillan, RR, Victor, DW, Minze, LJ, Gaber, AO & Ghobrial, RM 2021, , Annals of surgery, vol. 274, no. 3, pp. 411-418. https://doi.org/10.1097/SLA.0000000000004998

Management of intrahepatic cholangiocarcinoma
Kodali, S, Shetty, A, Shekhar, S, Victor, DW & Ghobrial, RM 2021, , Journal of Clinical Medicine, vol. 10, no. 11, 2368. https://doi.org/10.3390/jcm10112368

An imageomics and multi-network based deep learning model for risk assessment of liver transplantation for hepatocellular cancer
He, T, Fong, JN, Moore, LW, Ezeana, CF, Victor, D, Divatia, M, Vasquez, M, Ghobrial, RM & Wong, STC 2021, , Computerized Medical Imaging and Graphics, vol. 89, 101894. https://doi.org/10.1016/j.compmedimag.2021.101894

Nonalcoholic fatty liver disease after liver transplant
Shetty, A, Giron, F, Divatia, MK, Ahmad, MI, Kodali, S & Victor, D 2021, , Journal of Clinical and Translational Hepatology, vol. 9, no. 3, pp. 428-435. https://doi.org/10.14218/JCTH.2020.00072

Survival following liver transplantation for locally advanced, unresectable intrahepatic cholangiocarcinoma
McMillan, RR, Javle, M, Kodali, S, Saharia, A, Mobley, C, Heyne, K, Hobeika, MJ, Lunsford, KE, Victor, DW, Shetty, A, McFadden, RS, Abdelrahim, M, Kaseb, A, Divatia, M, Yu, N, Nolte Fong, J, Moore, LW, Nguyen, DT, Graviss, EA, Gaber, AO, Vauthey, JN & Ghobrial, RM 2022, , American Journal of Transplantation, vol. 22, no. 3, pp. 823-832. https://doi.org/10.1111/ajt.16906

Successful Treatment of Invasive Mucormycosis in Orthotopic Liver Transplant Population
Eubank, TA, Mobley, CM, Moaddab, M, Hobeika, MJ, ONeal, M, Musick, WL, Knight, JM, Galati, JS, Kodali, S, Shetty, A, Victor, DW, Saharia, A, Ghobrial, RM & Grimes, KA 2021, , Case reports in transplantation, vol. 2021, pp. 8667589. https://doi.org/10.1155/2021/8667589

Patterns of Alcohol Use After Early Liver Transplantation for Alcoholic Hepatitis
Lee, BP, Im, GY, Rice, JP, Lazar, A, Weinberg, E, Han, H, Maddur, H, Ghobrial, RM, Therapondos, G, Hsu, C, Fix, OK, Eswaran, S, Shetty, K, Chhatwal, J, Dalgic, OO, Jakhete, N, Mobley, C, Victor, DW, Mehta, N, Dinges, L, Rinella, M, Schiano, TD, Lucey, MR & Terrault, N 2020, , Clinical Gastroenterology and Hepatology, vol. 20, no. 2, pp. 409-418.e5. https://doi.org/10.1016/j.cgh.2020.11.024

Proceedings of the 25th annual congress of the international liver transplantation society
Chadha, R, De Martin, E, Kabacam, G, Kirchner, V, Kalisvaart, M, Goldaracena, N, Tanaka, T, Spiro, M, Sapisochin, G, Vinaixa, C, Hessheimer, A, Campos Varela, I, Rammohan, A, Yoon, YI, Victor, D, Scalera, I, Chan, A & Bhangui, P 2020, , Transplantation, vol. 104, no. 8, pp. 1560-1565. https://doi.org/10.1097/TP.0000000000003160

Prospective Multicenter Study of Early Antiviral Therapy in Liver and Kidney Transplant Recipients of HCV-Viremic Donors
Terrault, NA, Burton, J, Ghobrial, M, Verna, E, Bayer, J, Klein, C, Victor, D, Mohan, S, Trotter, J, Dodge, J, Niemann, CU & Rubin, RA 2020, , Hepatology, vol. 73, no. 6, pp. 2110-2123. https://doi.org/10.1002/hep.31551

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
REGENERATE Study Investigators 2019, , The Lancet, vol. 394, no. 10215, pp. 2184-2196. https://doi.org/10.1016/S0140-6736(19)33041-7

Delayed autologous stem cell transplantation following cardiac transplantation experience in patients with cardiac amyloidosis
Trachtenberg, BH, Kamble, RT, Rice, L, Araujo-Gutierrez, R, Bhimaraj, A, Guha, A, Park, MH, Hussain, I, Bruckner, BA, Suarez, EE, Victor, III, DW, Adrogue, HE, Baker, KR & Estep, JD 2019, , American Journal of Transplantation, vol. 19, no. 10, pp. 2900-2909. https://doi.org/10.1111/ajt.15487

Model to Calculate Harms and Benefits of Early vs Delayed Liver Transplantation for Patients With Alcohol-Associated Hepatitis
Lee, BP, Samur, S, Dalgic, OO, Bethea, ED, Lucey, MR, Weinberg, E, Hsu, C, Rinella, ME, Im, GY, Fix, OK, Therapondos, G, Han, H, Victor, DW, Voigt, MD, Eswaran, S, Terrault, NA & Chhatwal, J 2019, , Gastroenterology, vol. 157, no. 2, pp. 472-480.e5. https://doi.org/10.1053/j.gastro.2019.04.012

Outcomes of Liver Transplantation for Hepatocellular Carcinoma beyond the University of California San Francisco Criteria: A Single-center Experience
Victor, III, DW, Monsour, HP, Boktour, M, Lunsford, K, Balogh, J, Graviss, EA, Nguyen, DT, McFadden, RS, Divatia, MK, Heyne, K, Ankoma-Sey, V, Egwim, C, Galati, J, Duchini, A, Saharia, A, Mobley, CM, Gaber, AO & Ghobrial, RM 2020, , Transplantation, vol. 104, no. 1, pp. 113-121. https://doi.org/10.1097/TP.0000000000002835

VIEW FULL PUBLICATIONS